Ninety One IPO set to proceed with £2bn valuation

Formerly Investec Asset Management

clock • 3 min read

Ninety One, the rebranded Investec Asset Management, will be valued at around £2bn when it comes to market, the company announced on Monday (2 March).

Ninety One said its flotation would be priced at between 190p and 235p, valuing the firm at between £1.7bn and £2.2bn. A valuation upwards of £2bn would put it on the fringes of the FTSE 100. The current smallest blue-chip stock in the UK, NMC Health, has a market cap of just shy of £2bn. However, with a reshufflejust around the corner and the next smallest, Micro Focus, at £2.4bn, it will likely land in the FTSE 250. The IPO will put 10% of the company's shares up for sale, with £180m to £226m expected to be raised. More than half of the company's shares will be owned by Investec shareh...

To continue reading this article...

Join Investment Week for free

  • Unlimited access to real-time news, analysis and opinion from the investment industry, including the Sustainable Hub covering fund news from the ESG space
  • Get ahead of regulatory and technological changes affecting fund management
  • Important and breaking news stories selected by the editors delivered straight to your inbox each day
  • Weekly members-only newsletter with exclusive opinion pieces from leading industry experts
  • Be the first to hear about our extensive events schedule and awards programmes

Join now

 

Already an Investment Week
member?

Login

More on Investment

Stories of the week: Defence spending, the FCA, and Brickwood

Stories of the week: Defence spending, the FCA, and Brickwood

The German election, Unilever, and UK GDP: The biggest stories from the world of investment and asset management this week

clock 28 February 2025 • 1 min read
Partner Insight: Uncovering the rich tapestry of emerging markets

Partner Insight: Uncovering the rich tapestry of emerging markets

Global emerging markets comprise a large and varied selection of economies and companies. And yet they are often treated as a homogeneous asset class. We seek to debunk some of the misconceptions about emerging markets and unveil the diverse range of potential opportunities they offer, says M&G Investments.

M&G Investments
clock 28 February 2025 • 3 min read
M&G's Matcham: Concentration risk, consolidation and 'reframing' the active debate

M&G's Matcham: Concentration risk, consolidation and 'reframing' the active debate

Building on history of innovation

Katrina Lloyd
clock 26 February 2025 • 6 min read
Trustpilot